BioSpace News Archive

Business

AstraZeneca Deepens Gene Editing Capabilities with Revvity Partnership

Under a non-exclusive agreement, AstraZeneca is licensing biotech Revvity’s base editing technology to help create cell therapies for the treatment of cancer and immune-mediated diseases.

May 18, 2023
·
2 min read
·
Tristan Manalac
Policy

SCOTUS Rules Against Amgen in PCSK9 Patent Dispute with Sanofi, Regeneron

The U.S. Supreme Court unanimously ruled Amgen’s cholesterol drug Repatha patents invalid, ending a protracted legal battle with competitors Sanofi and Regeneron.

May 18, 2023
·
2 min read
·
Lisa Munger
FDA

FDA Panel Backs Pfizer’s Maternal RSV Vaccine Despite Safety Concerns

An advisory committee of outside experts voted unanimously Thursday that Pfizer’s vaccine was effective in preventing severe disease, but some had questions regarding its safety.

May 18, 2023
·
3 min read
·
Tristan Manalac
Policy

Opinion: Sarepta Enters Uncharted Territory with Adcomm Approval

The extensive discussion between the FDA’s advisory committee, company representatives and other interested parties could serve as a cautionary tale to developers of future gene therapies.

May 18, 2023
·
3 min read
·
Jia Jie Chen
Drug Development

Biopharma Targets the Untapped Potential of the Human Healthspan

More than $5 billion poured into the longevity space in 2022, and experts say the science is now primed to make a real difference in extending human healthspan.

May 18, 2023
·
6 min read
·
Heather McKenzie
Policy

US Appeals Court Panel Questions FDA Due Diligence on Abortion Pill

A three-judge panel is reviewing the legal challenge to the FDA’s approval of mifepristone. Any action by the court may result in further appeals, and possibly another Supreme Court decision.

May 18, 2023
·
3 min read
·
Lisa Munger
Policy

New FDA Guidance Aims to Increase Number of Children in Clinical Trials

According to the FDA, the majority of therapies prescribed for children were not tested in pediatric populations. The new guidance aims to change that.

May 18, 2023
·
2 min read
·
Rosemary Scott
Business

SAIC Announces CEO Transition - May 18, 2023

Science Applications International Corp. announced the appointment of 35-year global technology veteran Toni Townes-Whitley as the company’s Chief Executive Officer, effective October 2, 2023.

May 18, 2023
·
6 min read
The Future of Medicine is Personalized

Patient-centered, holistic, personalized medicine is the future of healthcare. One-size-fits-all healthcare approaches are in the past, according to Lisa McDonald

May 18, 2023
·
3 min read
Biotech Bay

Structure Therapeutics Announces Poster Presentations at the American Thoracic Society International Conference

Structure Therapeutics Inc. announced that the Company will present three scientific posters at the upcoming 2023 American Thoracic Society International Conference taking place May 19-24, 2023, in Washington, DC.

May 18, 2023
·
5 min read